 REDWOOD CITY, Calif., March 03, 2021 GLOBE NEWSWIRE -- Soleno Therapeutics, Inc. Soleno NASDAQ: SLNO, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update and announced financial results for the fourth quarter and year ended December 31, 2020. 